Xeris Biopharma Holdings (XERS) Financials

$7.57

$0.12 (1.61%)

As on 14-Sep-2026 16:26EDT

Market cap

$1,358 Mln

Revenue (TTM)

$335 Mln

P/E Ratio

--

P/B Ratio

107.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	335.41	291.85	203.07	163.91	110.25	49.59
Cost of Revenue	55.87	53.41	36.83	28.65	22.63	13.32
Gross Profit	279.54	238.43	166.24	135.27	87.61	36.27
Operating Expenses	242.95	213.54	199.88	179.28	169.55	151.43
Operating Profit (EBIT)	36.59	24.90	-33.65	-44.01	-81.94	-115.16
Other Income	--	--	--	--	--	--
Profit before Tax	-17.17	0.55	-57.10	-63.50	-96.08	-122.73
Provision for Tax	--	--	-2.27	-1.25	-1.42	-0.11
Profit after Tax (Net Income)	-17.17	0.55	-54.84	-62.26	-94.66	-122.73
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-94.66	-122.73

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-9.73	13.69	-29.62	-6.78	45.19	95.23
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	232.07	260.26	252.23	234.19	225.71	130.09
Current Liabilities	189.57	109.57	100.44	95.19	73.62	79.04
Total Liabilities	601.47	383.53	323.06	322.60	344.52	304.36

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	137.15	143.21	155.40	166.34	157.70	161.77
Current Assets	274.76	240.31	167.66	156.26	186.82	142.60
Total Assets	601.47	383.53	323.06	322.60	344.52	304.36
Total Debt*	289.44	37.76	271.45	229.19	198.06	88.07
Net Current Assets	85.19	130.74	67.22	61.07	113.20	63.56

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	28.63	-36.98	-47.02	-102.89	-95.54
Cash Flow from Investing Activities	--	-0.70	4.88	-6.00	34.46	97.96
Cash from Financing Activities	--	11.39	36.17	-1.61	127.47	27.25
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.10	0.00	-0.37	-0.45	-0.70	-1.01
Cash EPS ($)	-0.10	0.07	-0.28	-0.36	-0.60	-0.99
Adjusted Book Value ($)	-0.06	0.08	--	--	0.33	0.78
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.16	-0.25	-0.34	-0.76	-0.78
Free Cash Flow per Share ($)	--	0.16	-0.25	-0.36	-0.76	-0.79

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	0.38	-23.62	-26.74	-44.38	-95.86
ROE (%)	--	-6.96	301.32	-324.20	-134.83	-223.81
ROA (%)	-3.33	0.16	-16.99	-18.66	-29.18	-59.38
EBIT Margin (%)	1.17	0.19	-13.11	-22.51	-74.36	-233.00
Net Margin (%)	-5.12	0.19	-27.00	-37.98	-85.86	-247.48
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	36.33	0.44	0.24	0.49	1.22	17.22
EBIT Growth (%)	176.08	102.08	27.85	55.00	29.05	2.80
Net Profit Growth (%)	46.36	101.01	11.92	34.23	22.87	2.27
EPS Growth (%)	51.90	1.01	0.18	0.35	0.31	0.57
Book Value Growth (%)	54.49	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	2,551.56	-9.22	-5.21	-1.91	-2.91
Price / Book Value	107.68	103.26	-17.07	-47.86	4.00	3.75
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	63.94	105.45	-50.40	-20.28	-3.71	-3.02
Close Price ($)	7.92	7.85	3.39	2.35	1.33	2.93
High Price ($)	10.08	10.08	3.87	3.07	3.17	7.94
Low Price ($)	4.52	3.14	1.69	0.97	1.14	1.77
Market Cap ($ Cr)	1,358.29	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	-19.40	2.76	-9.17	-33.79	4.38	0.92
Short term debt to equity ratio	-7.20	0.46	-0.72	-0.52	0.03	0.02
Current Ratio	1.45	2.19	1.67	1.64	2.54	1.80
Quick Ratio	1.02	1.57	1.19	1.23	2.20	1.57
Interest Coverage	0.39	0.02	-0.80	-1.39	-5.81	-16.09

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	17.32	17.49	19.90	23.91	27.96	35.20
Asset Turnover	0.65	0.83	0.63	0.49	0.34	0.24
Receivable days	--	57.24	71.60	78.02	79.99	81.57
Inventory Days	--	399.52	431.44	405.31	345.76	278.28
Payable days	--	18.35	68.70	103.10	109.17	199.20
Cash Conversion Cycle	--	438.41	434.34	380.23	316.58	160.65

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.